Tryptamine, N-ethyl-N-isopropyl · Indole, 3-[2-(ethylisopropylamino)ethyl] · N-Ethyl-N-isopropyltryptamine · 3-[2-(Ethylisopropylamino)ethyl]indole
SYNTHESIS: (from indole): To a well-stirred solution of 1.6 g indole in 30 mL anhydrous Et2O there was added, dropwise over the course of 30 min, a solution of 3.8 g (2.6 mL) oxalyl chloride in 30 mL anhydrous Et2O. Stirring was continued for an additional 15 min during which time there was the separation of indol-3-ylglyoxyl chloride as a crystalline solid. This intermediate was removed by filtration and washed with Et2O. It was used directly in the following step. This solid acid chloride was added to 3.6 g anhydrous ethylisopropylamine in Et2O, followed by the addition of an excess of 2 N HCl. The mixture was cooled, and the resulting product N-ethyl-N-isopropylindol-3-ylglyoxylamide was removed by filtration. The air-dried product weighed 2.2 g (62% yield) and had a melting point of 149–151 °C.
A solution of 2.0 g N-ethyl-N-isopropylindol-3-ylglyoxylamide in 50 mL anhydrous THF was added, dropwise, to 1.5 g LAH in 50 mL anhydrous THF which was well-stirred under an inert atmosphere. This was brought to reflux and held there for 3 h. The reaction mixture was cooled, and the excess hydride destroyed by the cautious addition of wet THF. A 15% NaOH solution was then added until the solids had a loose white cottage cheese character to them, and the mobile phase tested basic by external damp pH paper. These formed solids were removed by filtration, washed first with THF and then MeOH. The filtrate and washings were combined, dried over anhydrous MgSO4, and the solvent removed under vacuum. The residue set up to a crystalline mass weighing 1.6 g (90%). This was recrystallized from pentane to provide N-ethyl-N-isopropyltryptamine (EIPT) as a free base with a mp of 71–73°C. Indole can also serve as a precursor to
(from N-ethyltryptamine, + 130 (11%); parent ion 230 (1%). This base was converted to the hydrochloride salt, as described above.
DOSAGE: 24–40 mg, orally
DURATION: 4–6 hrs h
QUALITATIVE COMMENTS: (with 24 mgs, orally) “There is something strange going on, and I am feeling quite urpy, but I feel quite horny at the same time. What would it be like to be making love and vomiting at the same time? Something is not at peace with itself. No way. And then suddenly I am baseline, and there is nothing left.”
(with 40 mg, orally) “I see some similarities with
(with 40 mg, orally) “Within a half hour, I have sparkling and a very unsure tummy. This is on one hand strangely not erotic, and yet I am completely functional, sexually. Remarkable orgasm. But still not erotic. No visuals, no sound enhancement, no fantasy, so why is it up there at a plus 2? I don’t know, and I am pretty much baseline by the fifth hour.”
(with 40 mg, orally) “Within the hour, a very mild pre-nausea, which passed off in about 45 minutes. No visual effects at all. The dreams that night weren’t quite as satisfying as the excellent, nice, clear, pretty dreams with an earlier 30 mg trial. The night was full of chopped-up sleep, since I was up about once an hour to pee. Observation: there is some diuretic component to this material. Barely plus 1. Would not bother taking it again.”
EXTENSIONS AND COMMENTARY: Clearly this is not an exciting compound. So why go to the extensive bother to make it and test it? For the single reason that the diisopropyl analogue is totally weird, one of the two weird tryptamines that need to be explored. If everything went as predicted, then nothing would ever be discovered. One must look always for the aberration that will demand that you change your working hypotheses and become responsive to unexpected and unexplainable things.
This is why EIPT is interesting. Let me itemize these close relatives of the diisopropylamine analogue, maintaining one isopropyl group but letting the other be something different. What can be seen from all of this exploration?
|methyl||isopropyl||It seems to be psychedelic in the 25 mg area, but it has not been brought up to the 40 mg level.|
|ethyl||isopropyl||EIPT||An uncomfortable nausea and uncomfortable trip but no auditory disruptions.|
|propyl||isopropyl||(not yet evaluated)|
|isopropyl||isopropyl||Intense auditory distortion, at the 40 mg level.|
|butyl||isopropyl||(not yet evaluated)|
If it turns out that the diisopropyl substitution is an absolutely essential structural component of this sensory phenomenon, then it has become one of the most remarkable tools known for the study of the human auditory association area in the brain.
This is why all of this research is important. You can never tell what a new compound will do. So you must continue to make new compounds and you must continue to be the observer. It is truly an exciting world.
13 May 2016 · · Isomer Design
About TiHKAL · info
This version of Book II of TiHKAL is based on the Erowid online version created by Bo Lawler with the help of Erowid, from content generously provided in electronic format by the Authors.
The Erowid online version does not always align precisely with the printed version. Text appears to have been inserted, deleted, or changed at various points. Where the two are seen to diverge both the Erowid and print versions are given. Sharp-eyed readers are encouraged to report novel discrepancies.
As with PiHKAL, I’ve again attempted to reproduce the typographic style of the printed edition. I’ve again made minor changes to some chemical names in line with current nomenclature practice. Typically the change is little more than expanding a prefix or setting it in italics. The history page has further details.
“At the present time, restrictive laws are in force in the United States and it is very difficult for researchers to abide by the regulations which govern efforts to obtain legal approval to do work with these compounds in human beings.“No one who is lacking legal authorization should attempt the synthesis of any of the compounds described in these files, with the intent to give them to man. To do so is to risk legal action which might lead to the tragic ruination of a life. It should also be noted that any person anywhere who experiments on himself, or on another human being, with any of the drugs described herein, without being familiar with that drug’s action and aware of the physical and/or mental disturbance or harm it might cause, is acting irresponsibly and immorally, whether or not he is doing so within the bounds of the law.”
The copyright for Book I of TiHKAL has been reserved in all forms and it may not be distributed. Book II of TiHKAL may be distributed for non-commercial reproduction provided that the introductory information, copyright notice, cautionary notice and ordering information remain attached.
TiHKAL is the extraordinary record of the authors’ years exploring the chemistry and transformational power of tryptamines. This book belongs in the library of anyone seeking a rational, enlightened and candid perspective on psychedelic drugs.
Though Sasha and Ann have put Book II of TiHKAL in the public domain, available to anyone, I strongly encourage you to buy a copy. We owe them — and there’s still nothing quite like holding a real book in your hands.
TiHKAL (ISBN 0-9630096-9-9) is available for US$24.50 (plus $10 domestic first-class shipping) from Transform Press.Transform Press,
Berkeley, CA 94701
510 · 934 · 4930 (voice)
510 · 934 · 5999 (fax)